Gabapentin Dementia Lawsuit in Tennessee - Free Case Review

Free Case Review

Start Your Free Review

Answer 2-3 quick questions to review your potential case.

Key Takeaway

Tennessee is a critical gabapentin litigation state, combining high per-capita prescribing rates, early controlled substance scheduling, and severe opioid crisis overlap. Tennessee classified gabapentin as a Schedule V controlled substance in 2019 after the Tennessee Bureau of Investigation reported that gabapentin was the second most commonly identified drug in forensic cases statewide. The state's Appalachian eastern region and rural middle Tennessee were among the hardest hit by the opioid crisis, and gabapentin filled the prescribing void as opioid access was restricted. Tennessee's per-capita gabapentin prescribing rate exceeds the national average by more than 50 percent. Vanderbilt University Medical Center in Nashville provides the state's premier neuroscience resource, while the University of Tennessee Health Science Center in Memphis supports diagnostic capabilities in western Tennessee.

Written By

People's Justice Legal Research Team

Statute of Limitations

Tennessee: 1 year for personal injury (Tenn. Code Ann. § 28-3-104). Discovery rule applies for latent injuries — the limitations period begins when the plaintiff discovers or should have discovered the injury and its connection to gabapentin. Tennessee's 1-year SOL is the shortest in the country — claimants must act immediately.

1 year from discovery of injury

Filing Venue

Where to File in Tennessee

Tennessee gabapentin cases may be filed in the Eastern District (Knoxville, Chattanooga), Middle District (Nashville), or Western District (Memphis). Davidson County Circuit Court in Nashville handles complex pharmaceutical litigation. Tennessee follows modified comparative fault with a 49% bar (Tenn. Code Ann. § 29-11-103). The state does not cap compensatory damages in product liability cases. Tennessee's 1-year SOL is the shortest in the nation — gabapentin claimants must file immediately upon discovery of the drug-cognition connection.

Tennessee Data

Exposure in Tennessee

Source: IQVIA / TN CSMD PDMP data

Source: Tennessee Board of Pharmacy / TBI forensic data

Source: TBI Forensic Laboratory annual report

FAQ

Frequently Asked Questions

See details below.

Back to Gabapentin Dementia Lawsuit Lawsuit Overview